BRWA
LGND icon

B. Riley Wealth Advisors’s Ligand Pharmaceuticals LGND Stock Holding History

B. Riley Wealth Advisors’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-3,765
Closed -$282K – 634
2016
Q2 		$282K Buy
+3,765
New +$279K 0.06% 415
2014
Q3 		– Sell
-2,396
Closed -$93.1K – 1341
2014
Q2 		$93.1K Buy
+2,396
New +$97.2K 0.02% 755

Other funds holding LGND

BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.77B AUM 63.16% 1-Year Est. Return
CCMLC
Cardinal Capital Management LLC (Connecticut) Greenwich, Connecticut $365M AUM 18.32% 1-Year Est. Return

B. Riley Wealth Advisors's LGND Position: Q3 2016 in Review

B. Riley Wealth Advisors sold out of Ligand Pharmaceuticals (LGND) in Q3 2016, closing a stake of 3,765 shares — an estimated $282K sold.

B. Riley Wealth Advisors first reported a position in LGND in Q2 2014 and held it in 2 quarters. The position peaked at $282K in Q2 2016. 259 funds tracked by Wall St. Rank hold LGND as of Q3 2016.

  • B. Riley Wealth Advisors reported no remaining Ligand Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
  • B. Riley Wealth Advisors sold 3,765 Ligand Pharmaceuticals shares in Q3 2016, an estimated $282K.
  • B. Riley Wealth Advisors first reported a position in Ligand Pharmaceuticals in Q2 2014 and held it in 2 quarters.
  • B. Riley Wealth Advisors's Ligand Pharmaceuticals position peaked at $282K in Q2 2016.
  • 259 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q3 2016.

Based on B. Riley Wealth Advisors's 13F filing for Q3 2016, filed 14 Nov 2016.